Documentos relacionados

1. The Neurofibromatoses.
2. Comparison of the frequency of loss-of-function LZTR1 variants between schwannomatosis patients and the general population.
3. Impact of mind-body treatment interventions on quality of life in neurofibromatosis patients: A systematic review and meta-analysis.
4. The impact of a virtual mind-body program on resilience factors among international English-speaking adults with neurofibromatoses: secondary analysis of a randomized clinical trial.
5. Mindfulness, coping, and optimism as mechanisms of change in the 3RP-NF intervention.
6. Psychosocial profiles of risk and resiliency in neurofibromatoses: a person-centered analysis of illness adaptation.
7. Advancing neurofibromatosis and schwannomatosis clinical trial design: Consensus recommendations from the Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Collaboration.
8. Opportunities for the treatment of NF1-associated low-grade gliomas: how to decide on the best treatment options for patients?
9. Recommendations for the collection and annotation of biosamples for analysis of biomarkers in neurofibromatosis and schwannomatosis clinical trials.
10. Caveat mammalian target of rapamycin (mTOR) revisited: Neurofibromatosis.